US Stock MarketDetailed Quotes
IGC IGC Pharma
- 0.3777
- +0.0217+6.10%
Trading Nov 25 14:53 ET
29.25MMarket Cap-1888P/E (TTM)
0.3850High0.3582Low612.52KVolume0.3735Open0.3560Pre Close229.71KTurnover0.87%Turnover RatioLossP/E (Static)77.45MShares0.909952wk High3.98P/B26.46MFloat Cap0.250152wk Low--Dividend TTM70.04MShs Float71.1000Historical High--Div YieldTTM7.53%Amplitude0.0001Historical Low0.3750Avg Price1Lot Size
IGC Pharma Key Stats
Quarterly+Annual
YOY
| (Q2)Sep 30, 2024 | (Q1)Jun 30, 2024 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | (Q3)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 38.44%-996K | -19.35%-1.75M | 26.22%-5.2M | 65.33%-526K | 3.70%-1.59M | 4.03%-1.62M | 33.15%-1.47M | 5.56%-7.05M | -71.03%-1.52M | 31.96%-1.65M |
| Net income from continuing operations | 29.95%-1.72M | -14.60%-2.38M | -12.98%-13M | 28.41%-2.89M | -148.51%-5.59M | -0.37%-2.45M | 25.49%-2.08M | 23.38%-11.51M | 38.03%-4.03M | 5.54%-2.25M |
| Operating gains losses | ---- | ---- | -212.82%-44K | ---- | ---- | ---- | ---- | --39K | ---- | ---- |
| Depreciation and amortization | -8.23%145K | 4.52%162K | -3.04%637K | 7.19%164K | -6.98%160K | -7.06%158K | -4.32%155K | 0.92%657K | -7.27%153K | 3.61%172K |
| Other non cash items | ---- | ---- | ---- | ---- | ---32K | --43K | -177.94%-53K | ---- | ---- | ---- |
| Change In working capital | 51.61%188K | -58.11%62K | 138.54%1.89M | 1.39%1.67M | -6.12%-52K | 926.67%124K | 118.66%148K | -68.69%794K | -52.57%1.65M | 93.29%-49K |
| -Change in receivables | -118.18%-16K | 109.32%11K | -600.00%-25K | -129.55%-39K | 170.97%44K | 309.52%88K | -413.04%-118K | -90.00%5K | 238.46%132K | -148.00%-62K |
| -Change in inventory | --0 | 200.00%30K | 12.37%1.01M | -7.38%1.02M | -1,250.00%-23K | 103.91%5K | 113.51%10K | -53.52%897K | -41.62%1.1M | -97.18%2K |
| -Change in prepaid assets | -353.49%-109K | -457.58%-118K | -74.62%150K | 70.77%-19K | -23.77%93K | -90.67%43K | -54.79%33K | 9.24%591K | -108.94%-65K | 438.89%122K |
| -Change in payables and accrued expense | 1,182.76%314K | -36.05%149K | 181.63%440K | -26.05%406K | -486.21%-170K | 89.53%-29K | 129.80%233K | -243.73%-539K | -52.71%549K | 96.06%-29K |
| -Change in other current assets | -34.00%33K | -72.22%5K | 1,807.69%444K | 1,317.86%341K | 172.92%35K | 1,150.00%50K | -60.87%18K | 91.22%-26K | 90.41%-28K | -284.62%-48K |
| -Change in other current liabilities | -3.03%-34K | 46.43%-15K | 8.21%-123K | 8.82%-31K | 8.82%-31K | 0.00%-33K | 15.15%-28K | -109.38%-134K | -3.03%-34K | -13.33%-34K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 38.44%-996K | -19.35%-1.75M | 26.22%-5.2M | 65.33%-526K | 3.70%-1.59M | 4.03%-1.62M | 33.15%-1.47M | 5.56%-7.05M | -71.03%-1.52M | 31.96%-1.65M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -190.28%-65K | -2,520.00%-131K | -34.89%-317K | -33.47%-323K | -258.82%-61K | -60.44%72K | 96.84%-5K | 68.33%-235K | 56.24%-242K | 65.31%-17K |
| Net PPE purchase and sale | 63.89%-13K | -265.22%-38K | -141.23%-94K | -18.18%-13K | -78.95%-68K | -108.91%-36K | 118.11%23K | 210.14%228K | 80.00%-11K | -40.74%-38K |
| Net intangibles purchase and sale | -160.00%-52K | -232.14%-93K | -22.01%-377K | -87.88%-310K | 77.38%-19K | 31.03%-20K | 9.68%-28K | 42.24%-309K | 66.87%-165K | -281.82%-84K |
| Net investment purchase and sale | ---- | ---- | 200.00%154K | --0 | -75.24%26K | ---- | ---- | ---154K | ---66K | --105K |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -190.28%-65K | -2,520.00%-131K | -34.89%-317K | -33.47%-323K | -258.82%-61K | -60.44%72K | 96.84%-5K | 68.33%-235K | 56.24%-242K | 65.31%-17K |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -72.23%794K | 250,800.00%2.51M | 3,424.00%3.52M | 66,800.00%667K | -1K | 2,702.94%2.86M | 0.00%-1K | -97.59%100K | 0.00%-1K | 0 |
| Net issuance payments of debt | 0.00%-1K | 0.00%-1K | 0.00%-3K | --0 | ---1K | 0.00%-1K | 0.00%-1K | 0.00%-3K | 0.00%-1K | --0 |
| Net common stock issuance | -72.20%795K | --2.51M | 3,324.27%3.53M | --667K | --0 | 2,676.70%2.86M | --0 | -97.52%103K | --0 | --0 |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | -72.23%794K | 250,800.00%2.51M | 3,424.00%3.52M | 66,800.00%667K | ---1K | 2,702.94%2.86M | 0.00%-1K | -97.59%100K | 0.00%-1K | --0 |
| Net cash flow | ||||||||||
| Beginning cash position | 5.86%1.82M | -62.52%1.2M | -69.45%3.2M | -72.13%1.38M | -54.31%3.03M | -78.60%1.72M | -69.45%3.2M | -28.10%10.46M | -58.59%4.95M | -54.00%6.62M |
| Current changes in cash | -120.34%-267K | 142.33%624K | 72.26%-1.99M | 89.66%-182K | 0.96%-1.65M | 193.65%1.31M | 37.41%-1.47M | -76.81%-7.18M | -22.14%-1.76M | 32.65%-1.67M |
| Effect of exchange rate changes | -10.00%-11K | 100.00%2K | 92.68%-6K | -81.82%2K | 107.69%1K | 64.29%-10K | 101.92%1K | -215.38%-82K | 127.50%11K | -192.86%-13K |
| End cash Position | -48.91%1.55M | 5.86%1.82M | -62.52%1.2M | -62.52%1.2M | -72.13%1.38M | -54.31%3.03M | -78.60%1.72M | -69.45%3.2M | -69.45%3.2M | -58.59%4.95M |
| Free cash flow | 35.62%-1.08M | -24.21%-1.88M | 25.46%-5.71M | 49.56%-851K | 17.82%-1.67M | -5.35%-1.67M | 35.60%-1.52M | 6.89%-7.67M | -14.84%-1.69M | 17.56%-2.04M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Audit Opinions | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data